Term Upside as Neutron Prices Climb to $70 Million a Launch — BigGo Finance

Morgan Stanley reiterated an Overweight rating on Rocket Lab (RKLB) with a $103 price target, citing higher Neutron rocket pricing and strong order book. Rocket Lab raised Neutron's base launch price to $70M and booked $515M in contracts. Q3 revenue grew 73% YoY to $267.8M, but net loss widened. The company plans to acquire Iridium Communications (IRDM) for $8B, expected to close in mid-2027.

Original reporting
Published Nov 11, 2026, 6:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 6:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Term Upside as Neutron Prices Climb to $70 Million a Launch — BigGo Finance — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

The earnings beat and higher contract values suggest a re‑rating opportunity, while launch schedule delays keep near‑term volatility.

02

Market read

Strong earnings and pricing uplift could drive RKLB shares higher, but investors should monitor launch timeline and dilution effects.

03

What to watch

Cash flow remains modest; reliance on future Neutron flights adds execution risk.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Rocket Lab's Q3 results and updated Neutron pricing were disclosed for the first time, providing fresh data on its commercial trajectory.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Rocket Lab reported Q3 revenue of $267.8M beating guidance, raised Neutron launch price to $70M and booked $515M in contracts, indicating strong commercial traction.

Expected impact

likely upward pressure as investors price in higher backlog and revenue growth, tempered by delay risk.

Evidence & confidence

The combination of a 73% revenue surge, backlog growth, and higher contract pricing is material and new, supporting a bullish view despite execution timing concerns.

Market effects

Strengthens the small‑sat launch sector and may boost related suppliers and satellite operators.

U.S. space‑tech equities could see modest gains as Rocket Lab's outlook improves.

Highlights growing commercial demand for high‑price launch services worldwide.

Counterpoint

Delay to 2027 could postpone profitability, and dilution from the Iridium deal may offset upside.

Key entities

  • Rocket Lab

    U.S. listed small‑sat launch provider (ticker RKLB).

  • Iridium Communications

    Satellite communications firm being acquired by Rocket Lab.

Related articles

$RKLBMed

Could Rocket Lab Actually Climb 56%? Or Is Morgan Stanley Totally Wrong?

Morgan Stanley reduced its price target for Rocket Lab to $103, 56% above its Nov. 11 close of $66.15, while maintaining an Overweight rating. The company sold $2.4B in stock Q3 and delayed Neutron's first launch to 2027. Analysts expect 3 cents EPS for 2027, down from 16 cents a year ago. Rocket Lab reported record revenue of $268M, up 73%, but a wider GAAP loss of 12 cents per share.

$RKLBMedAI 8/10

$8 Billion Merger Stuck at FCC: SpaceX Accuses Iridium of Using Spectrum Objections to Block Starlink Ground Stations — BigGo Finance

Rocket Lab's $8B acquisition of Iridium Communications faces FCC review opposition from SpaceX, which claims Iridium's spectrum objections are anticompetitive. The deal, valued at $54 per share, is expected to close in 2027. SpaceX seeks to include Iridium's spectrum behavior in the FCC's public-interest assessment, while Rocket Lab and Iridium argue the merger is pro-competitive. The FCC must decide whether to consider spectrum disputes in merger reviews.

$RKLBHighAI 8/10

Rocket Lab CEO Says It Could Be ‘Extremely Profitable’ Without Neutron — But SpaceX Is Not The Only Reason It’s Building The Rocket

Rocket Lab CEO Peter Beck sees a $1 trillion market in space services, beyond the $10-20 billion launch market. The company's proposed $8 billion acquisition of Iridium Communications (IRDM) is expected to close in mid-2027. Neutron rocket's debut is delayed to 2027, with 16 flights booked, including 8 worth $515 million. RKLB stock is down 5% year-to-date, with mixed retail sentiment.

$RKLBMed

Rocket Lab Lands $150M OSC Loan Pledge for Neutron Rocket

Rocket Lab USA secured a conditional $150M loan from the Department of War's Office of Strategic Capital for its reusable Neutron rocket. Funds will expand production and add recovery vessels. The loan is subject to due diligence and other conditions. Neutron is designed to carry 13,000 kg to low Earth orbit, supporting satellite constellations and national security payloads. This is OSC's third $150M space-sector commitment.

$RKLBHighAI 8/10

Rocket Lab posts $268 million quarter, expects Neutron in 2027

Rocket Lab reported Q3 2026 revenue of $267.8M, up 73% YoY, exceeding forecasts. Net loss widened to $79.7M, with adjusted EBITDA at -$18.0M. Space systems revenue grew 88% to $214.8M. Neutron rocket's launch delayed to 2027 due to manufacturing issues. Backlog reached $3.57B, with $1B in new launch contracts. Iridium acquisition pending regulatory approval, expected to close in 2027.